PER 0.00% 7.7¢ percheron therapeutics limited

@samfiodiving@nottawombatWhat doesnt get mentioned here is with...

  1. 1,400 Posts.
    lightbulb Created with Sketch. 558
    @samfiodiving@nottawombat

    What doesnt get mentioned here is with the rare disease status and the prevalence of DMD there are many many companies vying to be the first across the line for more effective treatments. Some were not mentioned in the recent published presentations.
    If one of these beats PER by treating ambulant boys thereby reducing the chances of them becoming non ambulant, PER loses position and relevance.
    For all the "DD" on here (which it isnt), there is rarely info about competitors who might leapfrog PER in the DMD space

    They said they are working hard on advocacy - there is little to show they have been
    They said AF was working hard in the background - zero evidence to show any efforts to lift the profile of the business
    They awarded themselves $hitloads of options prior to achieving anything
    There seems a lack of pace or urgency overall.

    If you assess JG time in the role so far from what is visible here are the (visible) things he has presided over:
    Name change
    2 additional sites
    Few presentations and a few trips OS
    Ultra low cap raise
    Sold some unmarketable parcels
    Gave self many options before doing most to the above

    Whilst he is very knowledgeable and presents well, he hasnt done anything of substance to this point and whats more is yet to stamp his vision for the business into the minds of its holders, hes a good operator but not sure a CEO role is right for him - compare for example to CG and look at the difference.

    Whilst I remain a holder, it is hard to ignore the above items. It does make it difficult to want to invest more.
    Take the trial out of it as the timings are just estimates / advice given by Paraxel, what is of concern there, is that if this is such a huge opportunity, if they cannot recruit the very specific candidates into a trial in a reasonable time frame across many sites, how will they go if they do achieve the stage of a marketable drug? The TAM published by the company is also a very (overly) positive estimation obviously to try to swing punters into their favour but it hasn't had any impact in terms of attracting the right type of cornerstone investor (a David Williams or Allan Tribe type). Read more about some other thoughts here:https://shorter.gg/AjFhzk hope it works.

    GLAH

    Last edited by Deanostock: 25/04/24
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.7¢
Change
0.000(0.00%)
Mkt cap ! $69.41M
Open High Low Value Volume
7.7¢ 7.9¢ 7.6¢ $148.9K 1.895M

Buyers (Bids)

No. Vol. Price($)
1 48919 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 70000 1
View Market Depth
Last trade - 15.59pm 03/05/2024 (20 minute delay) ?
Last
7.8¢
  Change
0.000 ( 2.63 %)
Open High Low Volume
7.7¢ 7.9¢ 7.7¢ 43057
Last updated 13.04pm 03/05/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.